Display options
Cite
Gagnon J, Lévesque E, et al. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016;23(6):e615-e625doi: 10.3747/co.23.2961.
Gagnon, J., Lévesque, E., Borduas, F., Chiquette, J., Diorio, C., Duchesne, N., Dumais, M., Eloy, L., Foulkes, W., Gervais, N., Lalonde, L., L'Espérance, B., Meterissian, S., Provencher, L., Richard, J., Savard, C., Trop, I., Wong, N., Knoppers, B. M., & Simard, J. (2016). Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Current oncology (Toronto, Ont.), 23(6), e615-e625. https://doi.org/10.3747/co.23.2961
Gagnon, J, et al. "Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies." Current oncology (Toronto, Ont.) vol. 23,6 (2016): e615-e625. doi: https://doi.org/10.3747/co.23.2961
Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21. PMID: 28050152; PMCID: PMC5176389.
Copy Download .nbib Format: NLM
Share it on

Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21.

Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.

Current oncology (Toronto, Ont.)

J Gagnon, E Lévesque, F Borduas, J Chiquette, C Diorio, N Duchesne, M Dumais, L Eloy, W Foulkes, N Gervais, L Lalonde, B L'Espérance, S Meterissian, L Provencher, J Richard, C Savard, I Trop, N Wong, B M Knoppers, J Simard

Affiliations

  1. Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong).
  2. Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard).
  3. Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire (chu) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard);; Joliette, QC: Centre hospitalier régional de Lanaudière (Eloy).
  4. Rivière-du-Loup, QC: Centre hospitalier du Grand-Portage (Gervais).
  5. St-Raymond, QC: Centre de santé et de services sociaux de Portneuf (Savard).

PMID: 28050152 PMCID: PMC5176389 DOI: 10.3747/co.23.2961

Abstract

In recent years, risk stratification has sparked interest as an innovative approach to disease screening and prevention. The approach effectively personalizes individual risk, opening the way to screening and prevention interventions that are adapted to subpopulations. The international perspective project, which is developing risk stratification for breast cancer, aims to support the integration of its screening approach into clinical practice through comprehensive tool-building. Policies and guidelines for risk stratification-unlike those for population screening programs, which are currently well regulated-are still under development. Indeed, the development of guidelines for risk stratification reflects the translational aspects of perspective. Here, we describe the risk stratification process that was devised in the context of perspective, and we then explain the consensus-based method used to develop recommendations for breast cancer screening and prevention in a risk-stratification approach. Lastly, we discuss how the recommendations might affect current screening policies.

Keywords: Breast cancer; clinical practice; prevention; recommendations; screening

References

  1. Curr Opin Genet Dev. 2015 Feb;30:32-41 - PubMed
  2. Curr Oncol. 2016 Aug;23(4):e332-9 - PubMed
  3. Breast. 2015 Jun;24(3):237-41 - PubMed
  4. Br J Cancer. 2016 Apr 26;114(9):1045-52 - PubMed
  5. J Natl Cancer Inst. 2015 Apr 08;107(5):null - PubMed
  6. Genet Med. 2016 Dec;18(12 ):1190-1198 - PubMed
  7. J Natl Cancer Inst. 2014 Nov 12;106(11):null - PubMed
  8. Appl Transl Genom. 2014 Dec;3(4):82-83 - PubMed
  9. N Engl J Med. 2015 Jun 4;372(23):2243-57 - PubMed
  10. BMC Med Inform Decis Mak. 2012 Apr 10;12:30 - PubMed
  11. Lancet. 2012 Nov 17;380(9855):1778-86 - PubMed
  12. Br J Cancer. 2014 Jan 21;110(2):535-45 - PubMed
  13. J Natl Cancer Inst. 2002 Nov 6;94(21):1626-34 - PubMed
  14. N Engl J Med. 2008 Jun 26;358(26):2796-803 - PubMed
  15. Breast Cancer Res. 2014 Sep 28;16(5):446 - PubMed
  16. Nat Genet. 2000 Dec;26(4):411-4 - PubMed
  17. Breast Care (Basel). 2013 May;8(2):102-9 - PubMed
  18. Breast Cancer Res. 2010;12(3):R28 - PubMed
  19. J Natl Compr Canc Netw. 2009 Nov;7(10 ):1060-96 - PubMed
  20. Lancet. 2001 Oct 27;358(9291):1389-99 - PubMed
  21. Health Rep. 2009 Sep;20(3):7-19 - PubMed
  22. J Natl Cancer Inst. 2000 Jul 5;92 (13):1081-7 - PubMed
  23. Breast Cancer Res. 2012 Feb 07;14 (1):R25 - PubMed
  24. Breast Cancer Res. 2015 Dec 01;17 (1):147 - PubMed
  25. Acta Oncol. 2016;55(1):45-51 - PubMed
  26. N Engl J Med. 2015 Jun 11;372(24):2353-8 - PubMed
  27. J Natl Cancer Inst. 2014 Oct 01;106(11):null - PubMed
  28. N Engl J Med. 2012 Nov 22;367 (21):1998-2005 - PubMed
  29. Ann Intern Med. 2012 May 1;156(9):635-48 - PubMed
  30. Mol Oncol. 2010 Jun;4(3):174-91 - PubMed
  31. J Clin Oncol. 2013 Aug 10;31(23):2942-62 - PubMed
  32. J Clin Oncol. 2012 Sep 1;30(25):3136-40 - PubMed
  33. JAMA. 2016 Jan 5;315(1):68-76 - PubMed
  34. Br J Cancer. 2013 Jun 11;108(11):2202-4 - PubMed
  35. Nat Genet. 2013 Apr;45(4):349-51 - PubMed
  36. N Engl J Med. 2007 Jan 18;356(3):227-36 - PubMed
  37. Br J Cancer. 2011 May 10;104(10):1656-63 - PubMed
  38. PLoS One. 2009 Nov 11;4(11):e7695 - PubMed
  39. J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27 - PubMed
  40. J Intern Med. 2012 Apr;271(4):321-30 - PubMed
  41. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89 - PubMed
  42. Br J Cancer. 2013 Sep 3;109(5):1296-301 - PubMed
  43. Nat Genet. 2013 Apr;45(4):353-61, 361e1-2 - PubMed
  44. Nat Genet. 2015 Apr;47(4):373-80 - PubMed
  45. Lancet. 2013 May 25;381(9880):1827-34 - PubMed
  46. Cancer. 2014 Oct 1;120(19):2955-64 - PubMed
  47. Nat Rev Clin Oncol. 2016 Jan;13(1):41-54 - PubMed

Publication Types